Response Biomedical, a developer and marketer of rapid on-site diagnostic tests, has introduced its Ramp technology in the 3M Rapid Detection Flu A+B test, officially launching the Ramp influenza A/B Assay in the US. The test is branded by 3M as the 3M Rapid Detection Flu A+B Test.

INDIANAPOLIS, July 28 /PRNewswire/ -- Roche Diagnostics and Response Biomedical have entered into a partnership that will allow Roche to market the first line of cardiovascular tests for Response Biomedical's new point-of-care platform.